Hospital Groups Urge Federal Court to Uphold Maryland’s 340B Contract Pharmacy Access Law

American Hospital Association logo
AHA officials penned a Medical Economics op-ed on “the truth behind growth of the 340B prescription drug program.”
Groups representing Maryland providers along with national advocacy groups recently urged a federal judge to reject Novartis’ attempt to block [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Just Days Before New Laws Go Into Effect, GSK, Pfizer Exempt Additional States from Contract Pharmacy Restrictions

GlaxoSmithKline wordmark and GSK logo on a building
GlaxoSmithKline and Pfizer announced updates to their 340B contract pharmacy policies to comply with new state laws that will take effect in July.
Correction, Thursday, July 27, 2024, 7:00 p.m. EDT—The original version of this article mistakenly said Minnesota’s contract pharmacy access law [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Health Centers Fear ‘Collateral Damage’ From New Manufacturer Restrictions on Wholly-Owned Pharmacies

Ohio-based Signature Health will lose 340B drug access at its fully owned central fill pharmacy as a result of five new drugmaker policies.
Five new manufacturer restrictions on wholly-owned pharmacies taking effect in July will be “disastrous” for certain health center pharmacy arrangements, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Health Centers Urge Federal Appeals Court to Reverse Dismissal of Suit Alleging Drugmaker Collusion on Contract Pharmacy Restrictions

plaintiff table in a courtroom
Two community health centers urged a federal appeals court to reverse an earlier dismissal of their lawsuit alleging four major [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

California Hospital Association Pans ASAP 340B-Endorsed Bill, Encourages Congress to Support 340B PATIENTS Act

California
The California Hospital Association argued in a June 20 letter to the state’s congressional delegation that “core provisions” of the 340B Affording Care for Communities and Ensuring a Strong Safety-Net (340B ACCESS) Act “will reduce access to care for vulnerable populations.”
The California Hospital Association (CHA) is the latest organization to raise concerns about the 340B ACCESS Act, a bill recently [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

IRA Could ‘Crush the 340B Margin,’ Force Transparency into Program, Says Adam Fein of Drug Channels

Adam Fein, Ph.D., president of Drug Channels Institute, hosted a June 21 webinar that discussed the IRA's interaction with the 340B program.

The Inflation Reduction Act (IRA) may reduce 340B margins for certain high-cost drugs and drive more transparency into the program, an influential pharmaceutical supply chain analyst who has been a frequent 340B critic told an audience of stakeholders late last

Read More »

Michigan Hospitals, Former Lawmaker Target State Contract Pharmacy Protection Bill Ahead of Summer Recess

Michigan Senate chamber
A bill that would enact contract pharmacy protections in Michigan has garnered renewed attention from 340B supporters and critics, alike, in the final days before the state’s legislature is set to recess for the summer.
A bill that would enact contract pharmacy protections in Michigan has garnered renewed attention from 340B supporters and critics, alike, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Lilly Adds Significant New Restrictions on 340B Contract Pharmacy Access; Alleges Lack of Oversight by HRSA, Pharmacies and TPAs

Lilly wordmark on top of building
Pharmaceutical giant Eli Lilly has significantly escalated its restrictions on access to 340B pricing in the contract pharmacy setting, the company announced June 19 on the drug industry vendor site 340B ESP.
Pharmaceutical giant Eli Lilly has significantly escalated its restrictions on access to 340B pricing in the contract pharmacy setting, the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Lilly Posts 340B Refund Notice for Insulin Product Humulin

Eli Lilly and Amgen announced refunds for 340B covered entities that purchased certain drugs in 2021.
Drug manufacturer Eli Lilly announced a new round of refunds for Humulin, a brand-name insulin, following a 340B ceiling price [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

It’s Official: Long-Awaited Final 340B ADR Rule Takes Effect, But Findings Still Distant

The U.S. Department of Health and Human Services' final 340B Administrative Dispute Resolution rule formally took effect on June 18.
Fourteen years after the Congressional deadline, the long-anticipated revision to the 340B Administrative Dispute Resolution (ADR) process officially took effect [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live